oncology
Lung

Why it’s important to use the best treatment first in non-small cell lung cancer

Sponsored by Roche Products Pty Ltd

In a review of the evolution of tyrosine kinase inhibitors (TKIs) for the treatment of epidermal growth factor receptor (EGFR) mutated lung cancer, PhD candidate, Dr Pei Ding, a Medical Oncologist from the Nepean Cancer Care Centre painted a compelling picture to use the best treatments up front to her colleagues at the Roche Lung ...

Already a member?

Login to keep reading.


OR
© 2020 the limbic